Gabapentin
Product Images NDC 68151-1030

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68151-1030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1030)

The text seems to be a label from a Gabapentin 400 mg capsule produced by WIGACTAVIS with an expiration date of 09/16.*

FDA Label Image

2 (Gabapentin Capsules Elizabeth Edison 1)

This appears to be a formula for calculating the estimated glomerular filtration rate (eGFR) using an equation called "cLcr." The equation takes into account the patient's age and weight, as well as their serum creatinine level. The result is expressed in milliliters per minute per 1.73 meters squared (mL/min/1.73m²), and can be used to assess kidney function. It should be noted that this equation may not be as accurate as other methods for estimating eGFR, and should not be used in all cases.*

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 2)

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 3)

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 4)

FDA Label Image

1 (Gabapentin Capsules Elizabeth Edison 5)

FDA Label Image

1 (Gabapentin Capsules Elizabeth Edison 6)

The text describes a chart displaying the mean pain score for a study with two groups: one receiving a placebo and the other receiving 3600 mg/day of Gabapentin. The chart is divided into two periods: a dose titration period of an unspecified length, followed by a 4-week fixed dose period. The mean pain score for both groups is 10, with no further information provided on what scale the score is measured or what the baseline week(s) refer to.*

FDA Label Image

2 (Gabapentin Capsules Elizabeth Edison 7)

This text describes a table or graph displaying the mean pain score for different doses and periods of a medication, specifically gabapentin at 1800mg/day and 2400mg/day. The table or graph also appears to have information regarding the duration of the trial, with a 4-week fixed dose period and a titration period that is less than 3 weeks.*

FDA Label Image

3 (Gabapentin Capsules Elizabeth Edison 8)

FDA Label Image

4 (Gabapentin Capsules Elizabeth Edison 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.